Host Transcriptomics and Culture-Independent Testing for the Management of Febrile Neutropenia: Data From an Observational Study Conducted in a Bone Marrow Transplant Unit

By Immunexpress | January 26, 2026
PubMed

Abstract Background: Managing febrile neutropenia is challenging due to the limited sensitivity of blood culture (BC) and the lack of tools differentiating infectious from non-infectious fever. T2 magnetic resonance (T2MR) is a culture-independent system detecting bacteria (T2Bacteria) and yeasts (T2Candida); SeptiCyte RAPID is a host response assay providing a likelihood of sepsis (SeptiScore). Methods: We conducted an…

Read More

Immunexpress’ Sepsis Test Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA) for Paediatric Patients Suspected of Sepsis

By Immunexpress | January 20, 2026
Immunexpress - the signature diagnostics for sepsis

SeptiCyte RAPID® is the 1st and only test included in the ARTG for paediatric sepsis testing, which makes it a game changer in the battle against a life-threatening condition SEATTLE and BRISBANE, Australia, January 20 2026 – Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that…

Read More